Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jalal M. Abu-Shaweesh, M.D., is currently the Director of Neonatology at Fairview Hospital as well as Staff Neonatologist for Cleveland Clinic health system hospitals including Main Campus, Hillcrest, Fairview, and Marymount Hospitals.
In addition to his clinical appointments, Dr. Abu-Shaweesh also serves as Associate Professor of Pediatrics in Cleveland Clinic’s Department of Neonatology and Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He also is Director of a Neonatology Case Presentation conference that covers the management of various neonatal conditions and diseases for neonatal faculty, fellows, nurses, pediatrics residents and medical students.
Dr. Abu-Shaweesh is an established clinical and basic researcher with expertise in Control of Breathing and neonatal apnea and has published multiple literature reviews, research articles, and book chapters in peer reviewed journals and Neonatology textbooks. He also is an ad-hoc reviewer for multiple journals including J. Applied Physiology, Respiratory Physiology, and Pediatric Research.
He is currently a member of many national and international professional organizations including, Society for Pediatric Research, Perinatal Research Society, American Physiological Society and Society for Neuroscience. In the past he has served on the Council and is past-President of the Midwestern Society for Pediatric Research. Dr. Abu-Shaweesh also has served as a grant application reviewer for the National Institute of Health.
Dr. Abu-Shaweesh is board-certified in neonatal-perinatal medicine and pediatrics. He received his medical degree from the University of Jordan in Amman, Jordan. Dr. Abu-Shaweesh completed a pediatric internship and residency at the University of Iowa Hospitals and Clinics in Iowa City, Iowa followed by a fellowship in Neonatal/Perinatal Medicine at Rainbow Babies and Children’s Hospital in Cleveland, Ohio.
Due to his expertise, Dr. Abu-Shaweesh has been an invited speaker on topics such as ventilatory management, neonatal apnea, neonatal sepsis, and hyperbilirubinemia.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/9/2016, Dr. Abu-Shaweesh has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.